November 21, 2019
4 min read
Top Trends in Oncology Patient Support
Find out what access and adherence challenges patients will need to overcome in the evolving oncology market.
UBC Insights
Insights from
UBC's Expert Voices
Featured Updates
Blog
October 30, 2025
6 min read
Drug Repurposing in Rare Diseases: The Impact of Natural History Studies
Drug repurposing is transforming the landscape of rare disease treatment by leveraging existing medications for new uses. With significantly lower development costs and faster timelines, this approach is gaining traction—especially when supported by natural history studies that provide deep insights into disease progression and real-world treatment patterns.
Blog
October 23, 2025
6 min read
EMA Issues Guidance on Risk Minimisation Measures for Medicinal Products with Embryo-Foetal Risks
The EMA’s August 2025 guidance on embryo-foetal risk minimisation marks a pivotal step in harmonizing safety protocols across the EU. This blog breaks down the new Addendum I to GVP Module XVI, clarifying what constitutes a Pregnancy Prevention Programme and how risk minimisation tools can be effectively implemented without compromising patient access to essential treatments.
Blog
October 20, 2025
9 min read
To Rescue or Not to Rescue Your Study: How to Spot Trigger Points in Strategic Partnerships
Instability is woven into our industry’s DNA. We operate daily in a high-stakes, high-risk environment where financial pressures, regulatory changes, and patient lives hang in the balance. The CRO selection process reflects this tension, few other sectors require competitors to both challenge and collaborate with one another, often for the same client. Our ecosystem is […]
Posts by Date
Blog
Blog
October 3, 2019
3 min read
Are You Ready For Sentinel? | New RWE Safety Initiative
With continued investment in the RWE space, find out how to meet the needs of regulators, payers, and prescribers.
Blog
September 3, 2019
3 min read
Immunogenicity: Meeting the Safety Reporting Requirements
Discover why it is imperative to assess the potential of therapeutic proteins throughout the product lifecycle.
Videos
July 17, 2019
1 min read
DIA 2019: Watch the Wrap-up of UBC’s Participation
See more of the developments UBC's evidence development and safety & risk management teams discussed.
Blog
June 4, 2019
3 min read
UBC’s Patient & Physician Services Creative Services Department Recognized for Excellence in Advertising and Marketing
UBC was pleased to receive numerous Healthcare Marketing Report’s 36th Annual Healthcare Advertising Awards for their exemplary work.
Videos
April 5, 2019
1 min read
Dr. Annette Stemhagen Speaks to Pregnancy Exposure Registries
Learn about PERs and why partnering with an experienced team is so vital.
Videos
April 4, 2019
1 min read
UBC Presents Observational & Investigational Studies
Watch Chief Scientific Officer Dr. Annette Stemhagen discuss in this video.
Videos
April 3, 2019
1 min read
Natalie O’Donnell, Head of Safety & Risk Management, Presents a REMS Overview
Learn more about mandatory Risk Evaluation and Mitigation Strategies programs.
Blog
March 14, 2019
3 min read
5 Areas in Adverse Event Reporting to Consider
Discover where to look for outside of traditional AE reporting.
Previous
